NCT06559553
- Conditions
- NKTCL, Selinexor
- Locations
-
- Oncology Department of The First Affilliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Clinical trial condition
NKTCL
Explore clinical trials studying NKTCL. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
NKTCL trial results
Not Yet Recruiting
Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma
NCT07615283
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
Not Yet Recruiting
A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma
NCT07574528
- Conditions
- NKTCL
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, 广东省 - Guangdong Sheng, China